A Phase 2 Study to Evaluate the Safety and Efficacy of Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Paclitaxel (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Feb 2017 Planned number of patients changed from 53 to 65.
- 15 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Feb 2017.